Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 6593232, 7 pages
http://dx.doi.org/10.1155/2016/6593232
Research Article

Evaluation of Two Methods for Determination of CD64 as a Diagnostic Marker of Infection in Critically Ill Adults

1Intensive Care Unit, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
2Instituto Israelita de Ensino e Pesquisa Albert Einstein, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
3Clinical Laboratory, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
4Division of Medical Practice, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
5Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, USA

Received 25 July 2016; Revised 13 October 2016; Accepted 15 November 2016

Academic Editor: Anastasia Kotanidou

Copyright © 2016 Thiago Zinsly Sampaio Camargo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. Balk, “Severe sepsis and septic shock,” Critical Care Clinics, vol. 16, no. 2, pp. 179–192, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. ProCESS Investigators, D. M. Yealy, J. A. Kellum et al., “A randomized trial of protocol-based care for early septic shock,” The New England Journal of Medicine, vol. 370, no. 18, pp. 1683–1693, 2014. View at Publisher · View at Google Scholar
  3. G. R. Bernard, J.-L. Vincent, P.-F. Laterre et al., “Efficacy and safety of recombinant human activated protein C for severe sepsis,” The New England Journal of Medicine, vol. 344, no. 10, pp. 699–709, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. B. H. Davis, S. H. Olsen, E. Ahmad, and N. C. Bigelow, “Neutrophil CD64 is an improved indicator of infection or sepsis in emergency department patients,” Archives of Pathology and Laboratory Medicine, vol. 130, no. 5, pp. 654–661, 2006. View at Google Scholar · View at Scopus
  5. J. Cid, R. Aguinaco, R. Sánchez, G. García-Pardo, and A. Llorente, “Neutrophil CD64 expression as marker of bacterial infection: a systematic review and meta-analysis,” Journal of Infection, vol. 60, no. 5, pp. 313–319, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Allen, A. C. Bakke, M. Z. Purtzer, and A. Deodhar, “Neutrophil CD64 expression: distinguishing acute inflammatory autoimmune disease from systemic infections,” Annals of the Rheumatic Diseases, vol. 61, no. 6, pp. 522–525, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. P. C. Ng, G. Li, K. M. Chui et al., “Neutrophil CD64 is a sensitive diagnostic marker for early-onset neonatal infection,” Pediatric Research, vol. 56, no. 5, pp. 796–803, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Fjaertoft, L. D. Håkansson, K. Pauksens, G. Sisask, and P. Venge, “Neutrophil CD64 (FcγRI) expression is a specific marker of bacterial infection: a study on the kinetics and the impact of major surgery,” Scandinavian Journal of Infectious Diseases, vol. 39, no. 6-7, pp. 525–535, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Gros, M. Roussel, E. Sauvadet et al., “The sensitivity of neutrophil CD64 expression as a biomarker of bacterial infection is low in critically ill patients,” Intensive Care Medicine, vol. 38, no. 3, pp. 445–452, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. O. Oppegaard, B. Skodvin, A.-K. Halse, and N. Langeland, “CD64 as a potential biomarker in septic arthritis,” BMC Infectious Diseases, vol. 13, article 278, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Dimoula, O. Pradier, Z. Kassengera, D. Dalcomune, H. Turkan, and J.-L. Vincent, “Serial determinations of neutrophil CD64 expression for the diagnosis and monitoring of sepsis in critically ill patients,” Clinical Infectious Diseases, vol. 58, no. 6, pp. 820–829, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Calandra and J. Cohen, “The International Sepsis Forum Consensus Conference on Definitions of Infection in the Intensive Care Unit,” Critical Care Medicine, vol. 33, no. 7, pp. 1538–1548, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. J.-L. Vincent, J. Rello, J. Marshall et al., “International study of the prevalence and outcomes of infection in intensive care units,” The Journal of the American Medical Association, vol. 302, no. 21, pp. 2323–2329, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. W. A. Knaus, E. A. Draper, D. P. Wagner, and J. E. Zimmerman, “APACHE II: a severity of disease classification system,” Critical Care Medicine, vol. 13, no. 10, pp. 818–829, 1985. View at Publisher · View at Google Scholar · View at Scopus
  15. M. E. Charlson, P. Pompei, K. L. Ales, and C. R. MacKenzie, “A new method of classifying prognostic comorbidity in longitudinal studies: development and validation,” Journal of Chronic Diseases, vol. 40, no. 5, pp. 373–383, 1987. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Li, X. Huang, Z. Chen et al., “Neutrophil CD64 expression as a biomarker in the early diagnosis of bacterial infection: a meta-analysis,” International Journal of Infectious Diseases, vol. 17, no. 1, pp. e12–e23, 2013. View at Publisher · View at Google Scholar · View at Scopus